Figures & data
Table 1 Baseline characteristics of patients
Table 2 ROC curve analyses of the NLR, PLR, LMR, and PNI for 1-year DFS
Figure 1 ROC curves of NLR, PLR, LMR, and PNI for 1-year DFS.
Note: (A) NLR, (B) PLR, (C) LMR, and (D) PNI.
Abbreviations: AUC, area under the curve; DFS, disease-free survival; LMR, lymphocyte-monocyte ratio; NLR, neutrophil-lymphocyte ratio; PLR, platelet-lymphocyte ratio; PNI, prognostic nutritional index; ROC, receiver operating characteristic.
Table 3 Baseline characteristics stratified by NLR and PLR
Figure 2 Kaplan–Meier curves of NLR and PLR for DFS and OS.
Notes: (A) NLR for DFS, (B) PLR for DFS, (C) NLR for OS, (D) PLR for OS.
Abbreviations: DFS, disease-free survival; NLR, neutrophil-lymphocyte ratio; OS, overall survival; PLR, platelet-lymphocyte ratio.
Table 4 Multivariate analyses for DFS and OS
Table 5 Multivariate analyses of NLR and PLR for DFS and OS stratified by pTNM stage
Figure 3 Nomograms and their accuracy for predicting 1-year DFS in patients with resectable PDAC.
Notes: (A) Nomogram including NLR and PLR, (B) nomogram without NLR and PLR, (C) bootstrap-corrected AUCs for model including NLR and PLR, (D) bootstrap-corrected (BS) AUCs for model without NLR and PLR.
Abbreviations: AUCs, areas under the curve; DFS, disease-free survival; ECOG PS, Eastern Cooperative Oncology Group performance status; NLR, neutrophil-lymphocyte ratio; PDAC, pancreatic ductal adenocarcinoma; PLR, platelet-lymphocyte ratio.
